Come study with us! A new DPhil (PhD) studentship from the @HPRUezi , based at @PSIOxford. This great project will investigate exposure risks and proportionate biocontainment measures for emerging & high consequence infectious diseases. Apply by 5pm on 4th July. www.ndm.ox.ac.uk/study/dphil-...

Kudos to my friend and colleague Barry Atkinson, from Diagnostics and Pathogen Characterisation at UKHSA, who led this paper and also produced the impressive and very useful timeline figure.

Cases of high-consequence infectious diseases identified in the UK, 1962–2023 The management of patients with acute infectious diseases can present significant challenges, especially if the causative agent has a propensity for person-to-person transmission. In such cases, effec...

And now with a link that works... www.microbiologyresearch.org/content/jour...

Case series of the first five human infections with monkeypox virus clade Ib and report on the public health response, United Kingdom, October to November 2024 We report two importations of monkeypox virus clade Ib infection to the United Kingdom in 2024. The first was a traveller returning from Tanzania, Rwanda and Uganda, the second from Uganda. Both prese...

Case series of the first five human infections with monkeypox virus clade Ib and report on the public health response, United Kingdom, October to November 2024 www.eurosurveillance.org/content/10.2...

High consequence infectious disease cases in the UK between 1962 and 2023 - the definitive list, described in our latest paper: microbiologyresearch.org/content/journa… #HCID

New paper out in Lancet Microbe, describing the development and assessment of our multiplex Luminex assay for #Mpox 👇

www.thelancet.com/journals/lan...

In a ‘shocker’ decision, Japan approves mpox drug that failed in two efficacy trials Earlier European authorizations for tecovirimat are also being scrutinized in the face of fresh data

I meant to attach file in earlier post: www.science.org/content/arti...

Thanks. A whole new world...

The worsening mpox outbreak in Africa: a call to action The escalating incidence of mpox in Africa has led the Africa Centres for Disease Control and Prevention to declare its first-ever Public Health Emergency of Continental Security and prompted WHO to i...

🆕 Our commentary in Lancet ID: “The worsening mpox outbreak in Africa: a call to action.”

Urgent action is needed to:
1. Scale up testing/surveillance
2. Study research gaps
3. Invest in vaccines/therapeutics
4. Boost care quality
5. Tailor community outreach

www.thelancet.com/journals/lan...